OCREVUS
OCREVUS
Approved
DIN Number
02467224
Drug Class
Human
Market Date
Sep 21, 2017
Company
HC
Hoffmann-La Roche Limited
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02467224
AIG Number0159350001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AG08 OCRELIZUMAB
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification92:20.00
Health Canada Classification
ACTIVE INGREDIENTS (1)
OCRELIZUMABActive
Strength: 30 MG / ML
Monograph: OCRELIZUMAB